Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   HTML views PDF downloads Totals
10,603 Dovepress* 8,494+ 2,368 10,862
PubMed Central* 2,109 951 3,060
Totals 10,603 3,319 13,922
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar